Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

News & Events

FDA PRESS RELEASE

 
For Immediate Release: July 28, 2011
Media Inquiries: Shelly Burgess 301-796-4651; shelly.burgess@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
 
Unapproved emergency birth control medicine possibly in U.S. distribution may be ineffective and unsafe
 
The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital. These products may be counterfeit versions of the “morning after pill” and may not be safe or effective in preventing pregnancy.
 
Evital has not been approved by the FDA for use in the United States.
  
This potentially ineffective and suspect counterfeit emergency birth control may also be in distribution in some Hispanic communities in the United States. 
 
The packaging label of the potentially ineffective and suspect counterfeit version says, “Evital Anticonceptivo de emergencia, 1.5 mg, 1 tablet”, by “Fluter Domull”,(see picture below):
           
  Birth Control
 
Consumers should not take the Evital product if its packaging looks like the picture above.
 
Ø      Contact your doctor or health care professional if you have taken Evital labeled
 as the 1.5 mg tablet and experienced any problems.
 
Ø      There are FDA-approved emergency birth control medicines available both with a prescription, and over-the-counter without a prescription (if you are 17 years old or older).
 
Ø      You should talk with a doctor, pharmacist, or health care professional to find the FDA-approved emergency birth control medicine best for you.
 
FDA is asking for help from consumers who have information about Evital.
Please send an email to CDER_Ingredient_Adulteration@fda.hhs.gov  to provide information or if you have more questions.  
 
Any information received is confidential and will be used only to help in FDA’s effort to remove the potentially unsafe and ineffective versions from the U.S. marketplace.
 
Health care professionals and consumers are asked to report adverse events related to the use of suspect counterfeit versions of Evital to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program either online, by regular mail, by fax, or by phone.
  • Complete and submit the report online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For more information about counterfeit medicine, click on link below:
 
Press Release in Spanish:
http://wcms.fda.gov/FDAgov/NewsEvents/Newsroom/PressAnnouncements/UCM266301
 
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
 

Page Last Updated: 04/07/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.